Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02513784 · ClinicalTrials.gov registry record · NA
Trial to Assess the Effects of an Antimicrobial Mouthwash on the Esophageal Microbiome
A NA study of Esophageal Adenocarcinoma and Barrett's Esophagus, sponsored by Columbia University.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT02513784: Completed NA study of Esophageal Adenocarcinoma and Barrett's Esophagus, sponsored by Columbia University.
NCT02513784 is a NA study of Esophageal Adenocarcinoma and Barrett's Esophagus that has completed, run by Columbia University. The registered enrollment target is 20 participants, below the 308-participant average among 43 other Esophageal Adenocarcinoma trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02513784, a NA study of Esophageal Adenocarcinoma and Barrett's Esophagus, has completed, sponsored by Columbia University.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a randomized, open-label pilot study to assess whether treatment with chlorhexidine mouthwash can alter the esophageal and gastric cardia microbiome
Primary Outcome
Within individual change in relative abundance of F nucleatum in oral samples
Conditions Studied
Interventions
- DRUG Chlorhexidine gluconate
Study Locations (1)
New York
- Columbia University Medical Center - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2015-08 |
| Est. Completion | 2017-12 |
| Phase | NA |
What the finished NCT02513784 record still lists
NCT02513784 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 308-participant average among 43 other Esophageal Adenocarcinoma trials with a reported enrollment target (94% lower).
The record links to 3 conditions, with Esophageal Adenocarcinoma appearing as the primary indexed condition, and to 1 intervention - of which Chlorhexidine gluconate is the first listed.
NCT02513784 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT02513784 about?
NCT02513784 is a clinical study titled "Trial to Assess the Effects of an Antimicrobial Mouthwash on the Esophageal Microbiome". This is a randomized, open-label pilot study to assess whether treatment with chlorhexidine mouthwash can alter the esophageal and gastric cardia microbiome
What is the current status of trial NCT02513784?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2015-08. Estimated completion is 2017-12.
What conditions does trial NCT02513784 study?
This clinical trial studies the following conditions: Esophageal Adenocarcinoma, Barrett's Esophagus, Reflux Esophagitis.
What interventions are being tested in trial NCT02513784?
The interventions under investigation include: Chlorhexidine gluconate (DRUG).
Who is sponsoring clinical trial NCT02513784?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02513784 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Esophageal Adenocarcinoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02513784's enrollment target sits among peer trials
20 38th of 43 higher than 6 of 43 other Esophageal Adenocarcinoma trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Esophageal Adenocarcinoma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Minimally Invasive Molecular Approaches for the Diagnosis of Barrett's Esophagus and Esophageal Adenocarcinoma
RECRUITING · NA
-
Assessment of a Minimally Invasive Collection Device for Molecular Analysis of Esophageal Samples
RECRUITING · NA
-
Seattle Biopsy Protocol Versus Wide-Area Transepithelial Sampling in Patients With Barrett's Esophagus Undergoing Surveillance
RECRUITING · NA
-
Surveillance vs. Endoscopic Therapy for Barrett's Esophagus With Low-grade Dysplasia
RECRUITING · NA
-
Multi-Site Detection of Barrett's Esophagus in Patients Without Chronic GERD Symptoms
RECRUITING · NA
-
Esophageal Cytology With FISH in Detecting Esophageal Cancer
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia